2.575
price down icon6.25%   -0.145
 
loading
Hookipa Pharma Inc stock is traded at $2.575, with a volume of 18,005. It is down -6.25% in the last 24 hours and down -36.09% over the past month. HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.
See More
Previous Close:
$2.72
Open:
$2.66
24h Volume:
18,005
Relative Volume:
0.50
Market Cap:
$32.43M
Revenue:
$52.16M
Net Income/Loss:
$-48.60M
P/E Ratio:
-2.8297
EPS:
-0.91
Net Cash Flow:
$-77.48M
1W Performance:
-18.79%
1M Performance:
-36.09%
6M Performance:
-70.25%
1Y Performance:
-44.55%
1-Day Range:
Value
$2.57
$2.75
1-Week Range:
Value
$2.57
$3.25
52-Week Range:
Value
$2.57
$11.30

Hookipa Pharma Inc Stock (HOOK) Company Profile

Name
Name
Hookipa Pharma Inc
Name
Phone
0114318906360
Name
Address
350 FIFTH AVENUE, 72ND FLOOR, SUITE 7240, NEW YORK, NY
Name
Employee
124
Name
Twitter
@HookipaPharma
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
HOOK's Discussions on Twitter

Compare HOOK with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
HOOK 2.58 32.43M 52.16M -48.60M -77.48M -0.91
VRTX 448.67 115.74B 10.63B -479.80M -1.35B 13.33
REGN 744.97 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 588.56 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 249.22 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 103.27 24.49B 3.30B -501.07M 1.03B 11.54

Hookipa Pharma Inc Stock (HOOK) Upgrades & Downgrades

Date Action Analyst Rating Change
Dec-02-22 Downgrade BofA Securities Buy → Underperform
Nov-12-21 Downgrade Morgan Stanley Overweight → Equal-Weight
Apr-08-21 Initiated Morgan Stanley Overweight
Nov-03-20 Initiated Truist Buy
Oct-26-20 Initiated JMP Securities Mkt Outperform
Oct-19-20 Resumed H.C. Wainwright Buy
Sep-27-19 Initiated H.C. Wainwright Buy
May-13-19 Initiated BofA/Merrill Buy
May-13-19 Initiated RBC Capital Mkts Outperform
View All

Hookipa Pharma Inc Stock (HOOK) Latest News

pulisher
10:18 AM

Hookipa Pharma stock hits 52-week low at $2.62 amid market challenges - Investing.com India

10:18 AM
pulisher
Nov 19, 2024

Companies Like HOOKIPA Pharma (NASDAQ:HOOK) Could Be Quite Risky - Simply Wall St

Nov 19, 2024
pulisher
Nov 17, 2024

HOOKIPA Pharma Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance

Nov 17, 2024
pulisher
Nov 15, 2024

RBC Capital Mkts reiterated coverage on HOOKIPA Pharma with a new price target - Quantisnow

Nov 15, 2024
pulisher
Nov 15, 2024

HOOKIPA Pharma stock target lowered, maintains outlook on strategic direction - Investing.com UK

Nov 15, 2024
pulisher
Nov 15, 2024

HOOKIPA Pharma Inc (HOOK) Quarterly 10-Q Report - Quartzy

Nov 15, 2024
pulisher
Nov 15, 2024

Hookipa Pharma stock hits 52-week low at $3.4 amid market challenges - Investing.com Australia

Nov 15, 2024
pulisher
Nov 15, 2024

Hookipa Pharma Reports Q3 Earnings Amid Strategic Changes - TipRanks

Nov 15, 2024
pulisher
Nov 14, 2024

HOOKIPA Pharma Reports Third Quarter 2024 Financial Results and Provides Recent Business Updates - The Bakersfield Californian

Nov 14, 2024
pulisher
Nov 11, 2024

HOOKIPA Pharma's Eseba-vec Highlighted in SITC Late-Breaker - Quantisnow

Nov 11, 2024
pulisher
Nov 05, 2024

HOOKIPA Pharma's SWOT analysis: stock's potential in immunotherapy market - Investing.com

Nov 05, 2024
pulisher
Nov 05, 2024

HOOKIPA Pharma's SWOT analysis: stock's potential in immunotherapy market By Investing.com - Investing.com UK

Nov 05, 2024
pulisher
Oct 31, 2024

HOOKIPA Pharma to Present Eseba-vec Combo in Frontline HNSCC as a Late-Breaker Poster Presentation at SITC 2024 - Quantisnow

Oct 31, 2024
pulisher
Oct 31, 2024

HOOKIPA commences HPV16+ cancer adjuvant care trial - Investing.com India

Oct 31, 2024
pulisher
Oct 31, 2024

HOOKIPA commences HPV16+ cancer adjuvant care trial By Investing.com - Investing.com Nigeria

Oct 31, 2024
pulisher
Oct 30, 2024

HOOKIPA Pharma Doses First Patients with Eseba-vec as Adjuvant Therapy in Phase 2 Investigator Lead Trial for Head & Neck Cancer - The Manila Times

Oct 30, 2024
pulisher
Oct 30, 2024

HOOKIPA Pharma Doses First Patients with Eseba-vec as Adjuvant Therapy in Phase 2 Investigator - The Bakersfield Californian

Oct 30, 2024
pulisher
Oct 09, 2024

Hookipa Pharma stock hits 52-week low at $3.91 amid market challenges By Investing.com - Investing.com South Africa

Oct 09, 2024
pulisher
Oct 09, 2024

Hookipa Pharma stock hits 52-week low at $3.91 amid market challenges - Investing.com

Oct 09, 2024
pulisher
Oct 01, 2024

Hookipa Pharma stock hits 52-week low at $4.06 amid market challenges - Investing.com

Oct 01, 2024
pulisher
Sep 30, 2024

HOOKIPA Pharma's SWOT analysis: stock's potential in cancer immunotherapy - Investing.com

Sep 30, 2024
pulisher
Sep 27, 2024

HOOKIPA Pharma Inc.'s (NASDAQ:HOOK) 26% Dip In Price Shows Sentiment Is Matching Revenues - Simply Wall St

Sep 27, 2024
pulisher
Sep 24, 2024

HOOKIPA presents KRAS cancer treatment data By Investing.com - Investing.com South Africa

Sep 24, 2024
pulisher
Sep 24, 2024

HOOKIPA presents KRAS cancer treatment data - Investing.com India

Sep 24, 2024
pulisher
Sep 24, 2024

HOOKIPA Pharma to Present Strong Preclinical HB-700 Dataset - Marketscreener.com

Sep 24, 2024
pulisher
Sep 20, 2024

Squamous Cell Carcinoma Clinical Trial Pipeline Insights: 75+ Key Companies Investigating Their Lead Candidates to Improve the Treatment Space | DelveInsight - GlobeNewswire Inc.

Sep 20, 2024
pulisher
Sep 17, 2024

Kaskela Law LLC Announces Shareholder Investigation of HOOKIPA Pharma Inc. (NASDAQ: HOOK) and Encourages Investors to Contact the Firm | FinancialContent Business Page - Financial Content

Sep 17, 2024
pulisher
Sep 16, 2024

How To Trade (HOOK) - Stock Traders Daily

Sep 16, 2024
pulisher
Sep 03, 2024

Wall Street Analysts Think HOOKIPA Pharma (HOOK) Could Surge 622.75%: Read This Before Placing a Bet - MSN

Sep 03, 2024
pulisher
Aug 31, 2024

HOOKIPA appoints new Non-Executive Chair as two members exit - Investing.com India

Aug 31, 2024
pulisher
Aug 30, 2024

HOOKIPA appoints new Non-Executive Chair as two members exit By Investing.com - Investing.com South Africa

Aug 30, 2024
pulisher
Aug 30, 2024

HOOKIPA Pharma Announces Board of Directors Changes - citybiz

Aug 30, 2024
pulisher
Aug 30, 2024

Hookipa Pharma Announces Board Restructuring and Appointments - TipRanks

Aug 30, 2024
pulisher
Aug 28, 2024

HOOKIPA Pharma to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - StockTitan

Aug 28, 2024
pulisher
Aug 27, 2024

Hookipa Pharma Inc (NASDAQ:HOOK) Short Interest Update - MarketBeat

Aug 27, 2024
pulisher
Aug 26, 2024

Will HOOKIPA Pharma Inc. (HOOK) Report Negative Q2 Earnings? What You Should Know - MSN

Aug 26, 2024
pulisher
Aug 17, 2024

HOOK (HOOKIPA Pharma) 3-Year FCF Growth Rate : 25.90% (As of Jun. 2024) - GuruFocus.com

Aug 17, 2024
pulisher
Aug 15, 2024

HOOK (HOOKIPA Pharma) 3-Year Revenue Growth Rate : -34.30% (As of Jun. 2024) - GuruFocus.com

Aug 15, 2024
pulisher
Aug 13, 2024

The Market Doesn't Like What It Sees From HOOKIPA Pharma Inc.'s (NASDAQ:HOOK) Revenues Yet As Shares Tumble 29% - Simply Wall St

Aug 13, 2024
pulisher
Aug 11, 2024

HOOKIPA Pharma Second Quarter 2024 Earnings: Revenues Miss Expectations - Yahoo Finance

Aug 11, 2024
pulisher
Aug 09, 2024

HOOK Stock Earnings: HOOKIPA Pharma Misses EPS, Misses Revenue for Q2 2024 - InvestorPlace

Aug 09, 2024
pulisher
Aug 08, 2024

The Globe and Mail - The Globe and Mail

Aug 08, 2024
pulisher
Aug 08, 2024

HOOKHOOKIPA Pharma Inc. Latest Stock News & Market Updates - StockTitan

Aug 08, 2024
pulisher
Aug 08, 2024

SEC Form 10-Q filed by HOOKIPA Pharma Inc. - Quantisnow

Aug 08, 2024
pulisher
Aug 08, 2024

HOOKIPA Pharma Reports Second Quarter 2024 Financial Results and Recent Business Highlights - ForexTV.com

Aug 08, 2024

Hookipa Pharma Inc Stock (HOOK) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Cap:     |  Volume (24h):